Archives
MTT Assays for Translational Thrombus Nanomedicine
2026-09-28
Thrombus-targeting performance changes with local blood flow, so translational studies need assays that separate delivery behavior from cellular response. This article examines how MTT can add a useful metabolic readout—while clarifying what it cannot establish about targeting or clinical efficacy.
Cardamomin Limits Oxidative Injury in Stroke Models
2026-09-27
A study of cardamomin from Amomum villosum Lour. links protection from hydrogen peroxide injury in BV-2 cells and cerebral ischemia in rats to MEK/ERK-dependent NRF2 activation and reduced AIFM1-associated cell death. The findings provide a mechanistic basis for further testing, while the models and reported assays do not yet establish clinical benefit or treatment efficacy after stroke.
Cyclic Pifithrin-α Hydrobromide in p53 Workflows
2026-09-26
Use this p53 inhibitor to test whether a stress phenotype depends on p53, while separating that question from broader DNA-damage or neuroinflammatory responses. A practical workflow pairs matched vehicle controls and p53-competent versus p53-deficient models with careful attention to stock handling and assay timing.
Topotecan HCl: Workflows for DNA-Damage Assays
2026-09-25
Use Topotecan HCl to probe topoisomerase 1-dependent DNA damage in cancer-cell workflows, from short cytotoxicity assays to longer sphere-forming studies. Practical dose ranges, handling guidance, and a carefully bounded connection to neuroinflammation research help researchers design interpretable experiments rather than assume one model predicts another.
Indomethacin: Practical Research Workflow Guide
2026-09-25
Indomethacin (SKU A8449) is a nonsteroidal anti-inflammatory drug for experiments examining cyclooxygenase activity and related inflammation research, with additional dossier-described PPAR and membrane effects. Use it with solvent-matched controls and endpoint-specific validation; it is not water-soluble, and the supplied product information does not establish a universal cell-treatment protocol or prove pathway specificity in a given model.
NiONPs, circ_0001944, and FXR/TLR4 in Fibrosis
2026-09-24
A 2025 study links hsa_circ_0001944 with FXR/TLR4 signaling and ferroptosis in nickel oxide nanoparticle–induced collagen formation. In rat and LX-2 cell models, FXR activation and circRNA overexpression were associated with reduced TLR4 expression and collagen deposition, highlighting a candidate pathway for further mechanistic study.
LDH Cytotoxicity Assay Kit: Workflow and QC
2026-09-24
The LDH Cytotoxicity Assay Kit measures LDH released into culture medium to support endpoint cell cytotoxicity measurement and cell damage quantification. It is useful for comparing membrane damage across treatment groups, but it does not identify a specific death pathway or replace mechanism-focused assays.
Viral RIPK3 Degradation Shapes Orthopoxvirus Inflammation
2026-09-23
Liu et al. identify a class of orthopoxvirus proteins that recruits host ubiquitin machinery to degrade RIPK3, suppressing necroptosis and altering viral replication and disease. The study connects this immune-evasion mechanism to host genotype and viral evolution, while highlighting why cell-death pathways must be distinguished when designing experiments.
Sulforaphane Workflows for Cancer and Inflammation
2026-09-23
Build reproducible Sulforaphane experiments that connect oxidative-stress biology with cell-cycle and inflammasome readouts. This guide translates cancer-cell and DSS-colitis evidence into practical dosing, assay-selection, and troubleshooting strategies.
CA800-PR Disrupts Golgi Signaling in HR+ Breast Cancer
2026-09-22
The reference study reports that the tumor-targeted heptamethine cyanine dye CA800-PR combines near-infrared imaging with selective suppression of progesterone receptor expression in HR+ breast cancer models. Its association with Golgi fragmentation, apoptosis, cytokine production, and M1-type macrophage enrichment suggests a therapeutic strategy distinct from conventional endocrine inhibition, while further validation is needed before clinical translation.
Large-Scale Gastruloid Arrays for Phenotype Screening
2026-09-22
Jan and colleagues developed an indexed magnetic microraft array that supports image-based analysis and automated sorting of individual human gastruloids at scale. The platform distinguished euploid from aneuploid gastruloids through DNA-area measurements and spatial-patterning gene expression, creating a practical route for single-structure developmental screening.
Tetrazolium (chloride) for Viability and Stroke Assays
2026-09-21
Tetrazolium (chloride), also known as Tetrazolium Red, converts dehydrogenase activity into a spatially resolved formazan signal for cell and tissue studies. Its strongest use case is the combination of quantitative mitochondrial readouts with ex vivo lesion mapping in ischemic injury research.
MTT Assays: From Metabolic Signal to Translation
2026-09-21
MTT is more than a routine viability reagent: its formazan signal is a mechanistic window into cellular redox activity. This thought-leadership guide explains how to use MTT to interrogate the miR-519d–Rab10–AMPK axis in hepatocellular carcinoma while avoiding overinterpretation of metabolic proxies.
(-)-Blebbistatin for Heat-Responsive Cardiac Assays
2026-09-20
Learn how (-)-Blebbistatin, a selective non-muscle myosin II inhibitor, can separate mechanical motion from temperature-dependent cardiac electrophysiology. This article translates HCN4 heat-sensing findings into practical assay-design decisions without confusing cytoskeletal perturbation with ion-channel modulation.
DFO for Reliable Latent Fingerprint Detection
2026-09-19
A scenario-based guide to selecting, preparing, and interpreting DFO (9H-1,8-Diazafluoren-9-one) for reproducible latent fingerprint workflows. It explains how SKU C6997 compares across formulation, documentation, handling, and suitability for forensic versus biomedical assays.
614 records 7/41 page Previous Next First page 上5页 678910 下5页 Last page